Phase II prospective trial correlating progression free survival with CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT01124695?term=E3108&rank=1

2. Intervention

   Tamoxifen citrate

3. Resource Description

   Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells. This phase II trial is studying how well tamoxifen citrate works in patients with metastatic or recurrent breast cancer.

4. Contact

   Berenberg, Jeffrey

5. PI

   Berenberg, Jeffrey

6. Topic

   breast cancer

7. Study Population

   Men and women at least 18 years old with estrogen receptor-positive and/or progesterone receptor-positive disease and measurable or non-measurable disease.

8. Website(s)

   http://www.cancer.gov/clinicaltrials/search/view?cdrid=672523&version=healthprofessional

9. Funded by

   Cancer Trials Support Unit

10. Phase

    Phase 2 clinical trial

11. Performed by

    Clinical Protocol & Data Management Shared Resource